Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
clostridium difficile
fda
life sciences
microbiome
2
×
national blog main
new york blog main
new york top stories
pfizer
2
×
san francisco blog main
san francisco top stories
10x genomics
abbvie
agtechfood
allergan
amgen
anemia
antibiotic
antibodies
astrazeneca
autism
autism spectrum disorder
avexis
biogen
biologic drugs
boston top stories
boulder/denver
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
colostrum
community-acquired bacterial pneumonia
crohn's disease
What
days
2
×
august
babies
bio
biotech
birth
born
breastfeed
busy
decisions
devices
drugs
fda
giving
gut
instructed
lands
legacy
microbiome
milk
mothers
news
nods
opioid
pantheryx
past
produce
reason
regulatory
roundup
sarepta’s
seven
shkreli’s
slow
soon
stumble
suits
target
tends
there’s
Language
unset
Current search:
microbiome
×
pfizer
×
days
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome